A cancer genomics company focused on advanced sequencing and data analytics used in precision oncology. Its platforms support pharmaceutical companies developing immuno-oncology therapies and provide molecular testing for cancer research and clinical applications. Investors track the firm for its ro...
1 member of Congress has disclosed 3 trades in Personalis, Inc. (PSNL), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 2 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2020-05-19 | Brian Mast | sell | $15K – $50K |
| 2020-04-22 | Brian Mast | sell | $1K – $15K |
| 2020-02-14 | Brian Mast | buy | $15K – $50K |